Literature DB >> 33614947

Choosing Between a Rock and the Pot Place.

Ariana M Nelson1.   

Abstract

In the evolving field of medicinal cannabis, there are many questions and concerns broached by patients to which health care providers cannot respond with anything other than anecdotal evidence. Many simple knowledge gaps persist due to barriers to high-quality research at the institutional and state levels: barriers that, in turn, stem from the federal designation of cannabis as an illegal substance. These perspectives of a California-based pain physician on the approach to the cannabis-curious pain patient highlight the necessity of a change in the classification of cannabis to streamline research as to the benefits and risks of this now ubiquitous substance. Copyright 2021, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  cannabinoid analgesia; drug abuse; medical marijuana; opioids; pain; public policy

Mesh:

Substances:

Year:  2021        PMID: 33614947      PMCID: PMC7891198          DOI: 10.1089/can.2020.0030

Source DB:  PubMed          Journal:  Cannabis Cannabinoid Res        ISSN: 2378-8763


  6 in total

1.  No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper.

Authors:  David H Epstein; Kenzie L Preston
Journal:  Am J Addict       Date:  2015-04-06

2.  Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.

Authors:  Ziva D Cooper; Gillinder Bedi; Divya Ramesh; Rebecca Balter; Sandra D Comer; Margaret Haney
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

Review 3.  Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data.

Authors:  Kent E Hutchison; Sarah L Hagerty; Jeffrey Galinkin; Angela D Bryan; L Cinnamon Bidwell
Journal:  Cannabis Cannabinoid Res       Date:  2019-09-23

4.  The impact of cannabis access laws on opioid prescribing.

Authors:  Benjamin J McMichael; R Lawrence Van Horn; W Kip Viscusi
Journal:  J Health Econ       Date:  2019-12-14       Impact factor: 3.883

5.  Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care.

Authors:  Alexis C Cooke; Kelly R Knight; Christine Miaskowski
Journal:  Int J Drug Policy       Date:  2018-11-23

6.  Mapping cannabis potency in medical and recreational programs in the United States.

Authors:  Mary Catherine Cash; Katharine Cunnane; Chuyin Fan; E Alfonso Romero-Sandoval
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.